Breast implant PMA approvals: who owns the FDA-approved implant market
Nine original PMA applications, 400 total PMA records, and the 2024 entry of Motiva: what the FDA premarket-approval database reveals about who makes the breast implants…
Fat reduction, muscle stimulation, skin tightening below the neck. What works, what's overpromised, and who isn't a candidate.
Nine original PMA applications, 400 total PMA records, and the 2024 entry of Motiva: what the FDA premarket-approval database reveals about who makes the breast implants…
347,618 FDA MAUDE reports on silicone and saline breast implants: rupture and capsular contracture dominate, BIA-ALCL reporting spiked with the 2019 Allergan recall, and…
An evidence map of cellulite from 62 clinical trials and the FDA record: Cellfina subcision lasts longest, RESONIC clears dimples in one session, and the Qwo injectable…
11,280 FDA MAUDE reports under cryolipolysis code OOK: 95.1% describe paradoxical adipose hyperplasia (PAH), reporting surged a thousand-fold from 2019 to 2023, and…
526 FDA MAUDE reports on liposuction devices show injuries and malfunctions split nearly even, VASER ultrasound systems dominate, and thermal burns are the signature…
Buccal fat removal (bichectomy) permanently reduces cheek fullness. A 2025 meta-analysis of 308 patients found a 25% complication rate, and the long-term aging question…
Emsculpt Neo combines HIFEM and RF for fat reduction and muscle building. Here is what clinical evidence supports, where marketing overreaches, and who should skip it.
CoolSculpting costs $2,000–$4,500 per treatment area on average. But the real number depends on applicator type, session count, body area, and provider. Here is how…
GLP-1 drugs drive major weight loss but leave excess skin, stubborn fat, and facial volume loss. Evidence-based guide to surgical and non-surgical contouring options…
Paradoxical adipose hyperplasia after CoolSculpting is rarer than manufacturers report. A 2025 meta-analysis found incidence 6.67x higher than stated. Covers PAH signs,…